Anna Dimberg
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Immunology top 1%
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Angiogenesis and VEGF in Cancer 31
- Retinoids in leukemia and cellular processes 7
- Immunology 32
- Immune cells in cancer 11
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 7
- Co-authors
- Lena Claesson‐Welsh (12 shared papers)Anna‐Karin Olsson (11 shared papers)Johan Kreuger (2 shared papers)Roberta Lugano (18 shared papers)Mohanraj Ramachandran (12 shared papers)Kenneth Nilsson (8 shared papers)Maria Georganaki (12 shared papers)Fredrik Öberg (9 shared papers)
- Journals
- Blood (8 papers)Cancer Research (6 papers)Nature Communications (5 papers)The FASEB Journal (4 papers)Frontiers in Immunology (3 papers)
- Partner nations
- SwedenItalyUnited States
In The Last Decade
Anna Dimberg
90 papers receiving 7.6k citations
Anna Dimberg's Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 1.5k
- Immunology 1.7k
- Oncology 2.2k
- Immunology and Allergy 471
- Molecular Biology 4.5k
Countries citing papers authored by Anna Dimberg
This map shows the geographic impact of Anna Dimberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Dimberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Dimberg more than expected).
Fields of papers citing papers by Anna Dimberg
This network shows the impact of papers produced by Anna Dimberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Dimberg. The network helps show where Anna Dimberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Dimberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | VEGF receptor signalling ? in control of vascular function Hit paper breakdown → | 2006 | 2483 |
| 2 | Tumor angiogenesis: causes, consequences, challenges and opportunities Hit paper breakdown → | 2019 | 1358 |
| 3 | 2005 | 220 | |
| 4 | 2015 | 197 | |
| 5 | 2014 | 154 | |
| 6 | 2003 | 133 | |
| 7 | 2018 | 132 | |
| 8 | 2002 | 121 | |
| 9 | 2012 | 119 | |
| 10 | 2017 | 116 | |
| 11 | 2013 | 112 | |
| 12 | 2007 | 112 | |
| 13 | 2021 | 107 | |
| 14 | 2021 | 100 | |
| 15 | 2018 | 97 | |
| 16 | 2009 | 95 | |
| 17 | 2005 | 87 | |
| 18 | 2010 | 82 | |
| 19 | 2023 | 78 | |
| 20 | 2007 | 75 |
About Anna Dimberg
Anna Dimberg is a scholar working on Molecular Biology, Immunology, Oncology, Cell Biology and Cancer Research, having authored 92 papers that have together received 7.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (31 papers), Cell Adhesion Molecules Research (15 papers), Glioma Diagnosis and Treatment (13 papers), Immune cells in cancer (11 papers), Immunotherapy and Immune Responses (8 papers), Cytokine Signaling Pathways and Interactions (7 papers), Retinoids in leukemia and cellular processes (7 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Cancer Research (1.5k citations), Immunology (1.7k citations), Oncology (2.2k citations), Immunology and Allergy (471 citations) and Molecular Biology (4.5k citations). Anna Dimberg has collaborated with scholars based in Sweden, Italy and United States. Frequent co-authors include Lena Claesson‐Welsh, Anna‐Karin Olsson, Johan Kreuger, Roberta Lugano, Mohanraj Ramachandran, Kenneth Nilsson, Maria Georganaki, Fredrik Öberg, Hua Huang and Lei Zhang. Their work appears in journals such as Blood, Cancer Research, Nature Communications, The FASEB Journal and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.